ATOS - Financial Reports List - Atossa Therapeutics, Inc. - IntrinsicAlpha

Atossa Therapeutics, Inc. ATOS

Healthcare - Biotechnology - NASDAQ - US

$ 0.8491

1.43 %

$ 110 M

Market Cap

-4.25

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-14.29%	100.00%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	18.15%	20.71%
Annual Report	FY	10-K	2024-12-31	0.00%	15.25%	11.97%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-16.07%	14.50%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	38.46%	8.83%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-7.64%	1.66%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-13.30%	-10.83%
Annual Report	FY	10-K	2023-12-31	0.00%	-14.74%	-13.31%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	20.31%	8.98%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-45.65%	-18.17%

1